Indian Drug Manufacturers Association (IDMA) is supporting Pharmexcil’s iPHEX 2013 inaugural event and is organising a seminar on ‘India: Destination of Choice for Quality Medicines’ at iPHEX 2013 on April 24 and 25, 2013. The event is planned to attract the entire Indian pharma industry, as also the participation of about 400 foreign buyers and regulators from many countries.
A panel discussion on ‘Hassle Free Exports’ based on the Seminar theme will be held on the first day with industry stalwarts such as Smitesh Shah, Chairman and Managing Director, Calyx Chemicals and Pharmaceuticals, Dr Milind Joshi, President, Global Regulatory Management, JB Chemicals and Pharmaceuticals, Dr Ajit Dangi, President and Chief Executive Officer, Danssen Consulting, Dr Raja Smarta, Managing Director, Interlink Marketing Consulting and other experts as panellists. Utkarsh Palnitkar, Partner (Head of Transactions and Restructuring), KPMG India will moderate the panel discussion.
The second day will have an interesting presentation on ‘Pharma Branding’ by Sudarshan Jain, Managing Director, Healthcare Solutions, Abbott Healthcare, ‘Success Stories of Indian companies in Exports’ by Sriram Shrinivasan, Partner, Life Sciences, Accenture India, and others on relevant topics such as ‘Biosimilars – ‘Look before you Leap‘, ‘Financing Pharma Exports ‘ etc.
An interactive session with overseas Regulators is also scheduled on the second day, wherein they will be requested to highlight their regulatory framework and how they can help in easing import of medicines from India.
This seminar will ensure delegates take home the skills to enable them and their teams to perform to the peak of their abilities, and build ‘Made in India’ pharma brands for global markets.
EP News Bureau – Mumbai
- Advertisement -
